MarkWThrunMD
Infectious Disease • Denver, COAssociate Professor, Medicine, University of Colorado School of Medicine
Are you Dr. Thrun?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Mc 7782
Denver, CO 80204Phone+1 303-436-6000
Summary
- Dr. Mark Thrun, MD is an infectious disease specialist in Denver, Colorado. He is currently licensed to practice medicine in Colorado and Ohio. He is affiliated with Denver Health and is an Associate Professor at University of Colorado School of Medicine.
Education & Training
University of ColoradoFellowship, Infectious Disease, 2000 - 2003- University of ColoradoResidency, Internal Medicine, 2000 - 2003
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1995 - 1998
University of Cincinnati College of MedicineClass of 1995
Certifications & Licensure
CO State Medical License 2001 - 2025
OH State Medical License 1996 - 2001
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsRemdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre C Kalil, Heng Jiang
Open Forum Infectious Diseases. 2024-06-01 - 69 citationsRemdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun
Clinical Infectious Diseases. 2021-10-01 - 3 citationsClinical management of hospitalized COVID-19 patients in the United StatesEssy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Julie Gayle
Open Forum Infectious Diseases. 2021-09-28
Press Mentions
No Need for Risk Counseling After All HIV TestsFebruary 10th, 2016
Fostamatinib Helps Reduce Reliance on Oxygen in Severe COVID-19October 12th, 2023
Professional Memberships
- Member
